ArticleFrontiers in immunology2025

Dual targeting of EZH2 and PD-L1 in Burkitt's lymphoma enhances immune activation and induces apoptotic pathway.

Yurim Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.